The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cardinal Health Inc's Score
Industry at a Glance
Industry Ranking
44 / 159
Overall Ranking
120 / 4582
Industry
Pharmaceuticals
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
17
analysts
Buy
Current Rating
212.541
Target Price
+6.90%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Cardinal Health Inc Highlights
StrengthsRisks
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 222.58B.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 222.58B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 31.52%.
Fairly Valued
The company’s latest PE is 29.87, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 211.58M shares, decreasing 3.54% quarter-over-quarter.
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
Ticker SymbolCAH
CompanyCardinal Health Inc
CEOMs. Deborah L. Weitzman
Websitehttps://www.cardinalhealth.com/en.html
FAQs
What is the current price of Cardinal Health Inc (CAH)?
The current price of Cardinal Health Inc (CAH) is 198.830.
What is the symbol of Cardinal Health Inc?
The ticker symbol of Cardinal Health Inc is CAH.
What is the 52-week high of Cardinal Health Inc?
The 52-week high of Cardinal Health Inc is 214.930.
What is the 52-week low of Cardinal Health Inc?
The 52-week low of Cardinal Health Inc is 114.600.
What is the market capitalization of Cardinal Health Inc?
The market capitalization of Cardinal Health Inc is 47.32B.
What is the net income of Cardinal Health Inc?
The net income of Cardinal Health Inc is 1.56B.
Is Cardinal Health Inc (CAH) currently rated as Buy, Hold, or Sell?
According to analysts, Cardinal Health Inc (CAH) has an overall rating of Buy, with a price target of 212.541.
What is the Earnings Per Share (EPS TTM) of Cardinal Health Inc (CAH)?
The Earnings Per Share (EPS TTM) of Cardinal Health Inc (CAH) is 6.656.